Sarepta Therapeutics, Inc. (SRPT)
18.13
-0.66
(-3.51%)
USD |
NASDAQ |
Aug 24, 16:00
18.13
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics Total Assets (Quarterly) : 3.189B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.189B |
| March 31, 2026 | 3.179B |
| December 31, 2025 | 3.350B |
| September 30, 2025 | 3.493B |
| June 30, 2025 | 3.680B |
| March 31, 2025 | 3.465B |
| December 31, 2024 | 3.963B |
| September 30, 2024 | 3.600B |
| June 30, 2024 | 3.424B |
| March 31, 2024 | 3.224B |
| December 31, 2023 | 3.265B |
| September 30, 2023 | 3.110B |
| June 30, 2023 | 3.126B |
| March 31, 2023 | 3.060B |
| December 31, 2022 | 3.128B |
| September 30, 2022 | 3.156B |
| June 30, 2022 | 2.997B |
| March 31, 2022 | 3.056B |
| December 31, 2021 | 3.148B |
| September 30, 2021 | 2.662B |
| June 30, 2021 | 2.759B |
| March 31, 2021 | 2.765B |
| December 31, 2020 | 2.985B |
| September 30, 2020 | 2.781B |
| June 30, 2020 | 2.883B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.947B |
| December 31, 2019 | 1.823B |
| September 30, 2019 | 1.702B |
| June 30, 2019 | 1.748B |
| March 31, 2019 | 1.964B |
| December 31, 2018 | 1.642B |
| September 30, 2018 | 1.183B |
| June 30, 2018 | 1.247B |
| March 31, 2018 | 1.300B |
| December 31, 2017 | 1.308B |
| September 30, 2017 | 800.28M |
| June 30, 2017 | 450.14M |
| March 31, 2017 | 511.53M |
| December 31, 2016 | 424.10M |
| September 30, 2016 | 487.31M |
| June 30, 2016 | 204.07M |
| March 31, 2016 | 213.36M |
| December 31, 2015 | 273.78M |
| September 30, 2015 | 184.75M |
| June 30, 2015 | 231.71M |
| March 31, 2015 | 242.71M |
| December 31, 2014 | 295.03M |
| September 30, 2014 | 319.06M |
| June 30, 2014 | 337.31M |
| March 31, 2014 | 275.39M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Moderna, Inc. | 10.96B |
| ImmunityBio, Inc. | 628.50M |
| X4 Pharmaceuticals, Inc. | 253.06M |
| MapLight Therapeutics, Inc. | 368.35M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.661B |
| Shareholders Equity (Quarterly) | 1.528B |
| Debt to Equity Ratio | 0.6845 |
| Current Ratio | 4.422 |
| Net Debt Paydown Yield | 3.14% |